Organizations Filed Purposes:
THE 340B PROGRAM REQUIRES DRUG MANUFACTURERS TO PROVIDE OUTPATIENT DRUGS AT REDUCED PRICES TO ELIGIBLE HOSPITALS, CLINICS, AND HEALTH CENTERS THAT SERVE LARGE LOW-INCOME AND RURAL PATIENT POPULATIONS. 340B HEALTH WAS FORMED IN 1993 TO EDUCATE AND ADVOCATE FOR HOSPITALS ELIGIBLE TO PARTICIPATE IN THE PROGRAM IN ORDER TO INCREASE THE AFFORDABILITY AND ACCESSIBILITY OF HEALTHCARE FOR PATIENTS IN NEED. MEMBER HOSPTIALS INCLUDE SOME OF THE NATION'S LARGEST ACADEMIC MEDICAL CENTERS AND SOME OF ITS SMALLEST RURAL COMMUNITY-BASED FACILITIES.
LEADING ADVOCATE & RESOURCE FOR THOSE HOSPITALS THAT SERVE THEIR COMMUNITIES THROUGH PARTICIPATION IN THE FEDERAL 340B DRUG PRICING PROGRAM.
EDUCATION - 340B HEALTH HELPS HOSPITALS, HEALTH SYSTEMS, PHARMACIES, AND OTHERS UNDERSTAND THE REQUIREMENTS OF 340B AND HELP THEM COMPLY WITH ITS RULES AND REGULATIONS. 340B HEALTH PROVIDES EDUCATION THROUGH REGULAR WEBINARS, REGIONAL ROUNDTABLES, NATIONAL CONFERENCES, AND ONLINE RESOURCES. WE ALSO CONDUCT ONE-ON-ONE TECHNICAL ASSISTANCE, UPON MEMBERS' REQUESTS. 340B HEALTH ALSO WORKS TO KEEP ITS MEMBERS AND STAKEHOLDERS INFORMED ABOUT CHALLENGES AND CHANGES TO 340B VIA VARIOUS ELECTRONIC COMMUNICATIONS AND THE WWW.340BHEALTH.ORG WEBSITE. 340B HEALTH ORGANIZES THE 340B COALITION'S ANNUAL WINTER AND SUMMER CONFERENCES (WWW.340BWINTERCONFERENCE.ORG AND WWW.340BSUMMERCONFERENCE.ORG) FEATURING DISCUSSIONS ABOUT COMPLIANCE AND OTHER OPERATIONAL MATTERS AND PUBLIC POLICY AND RELATED ACTIVITY.
ADVOCACY - 340B HEALTH WORKS WITH CONGRESS, REGULATORS, INVESTIGATORY AND ADVISORY AGENCIES, STATES, AND OTHERS TO HELP THEM UNDERSTAND THE 340B DRUG PRICING PROGRAM'S REQUIREMENTS, VALUE AND ROLE IN ADVANCING HEALTHY PATIENTS AND COMMUNITIES. WE CONDUCT INDEPENDENT RESEARCH REGARDING THE IMPACT AND EFFECTIVENESS OF THE 340B PROGRAM AND WORK WITH OUR MEMBERS TO CREATE PROFILES OF HOW 340B SAVINGS ARE USED TO IMPROVE PATIENT CARE AND COVER THE COST OF UNCOMPENSATED AND UNREIMBURSED PATIENT CARE. 340B HEALTH ADVOCATES FOR CHANGES IN POLICY NECESSARY TO IMPROVE THE PROGRAM AND ITS IMPACT.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
Name | Title | Hours Per Week | Total Salary |
Edward Slafsky | FORMER PRESIDENT AND CEO | 13 | $738,373 |
Maureen Testoni | PRESIDENT, CEO, AND GENERAL COUNSEL | 37 | $451,270 |
Robert Miller | SNR VP BUSINESS DEVELOPMEN | 45 | $308,854 |
Richard Sorian | SENIOR VP, COMMUNICATIONS | 45 | $262,719 |
Miriam Lasar | SNR VP FINANCE AND HR | 45 | $228,057 |
Anna Mangum | FORMER VP MEMBER AND BOARD RELATI | 23 | $205,340 |
Steven Miller | DIRECTOR OF PHARMACY SERVI | 45 | $204,282 |
Susan Pilch | SENIOR VP, LEGAL | 41 | $201,880 |
Michael Hess | VP OPERATIONS | 45 | $190,292 |
Kathryn Dibitetto | DIRECTOR, GOVERNMENT RELAT | 45 | $171,334 |
Amanda Nagrotsky | ASSISTANT COUNSEL | 45 | $163,171 |
Gregory Doggett | FORMER COUNSEL, LEGAL AND POLICY | 39 | $159,114 |
Tomas Mirga | FORMER EDITORIAL DIRECTOR | 38 | $120,054 |
Shane Kelley | DIRECTOR, MEMBERSHIP | 45 | $108,847 |
David Glendinning | DIRECTOR, COMMUNICATIONS | 45 | $107,327 |
Steve Petersen | DIRECTOR | 1 | $0 |
Charles Cooper | DIRECTOR | 1 | $0 |
Terry Andrus | DIRECTOR | 1 | $0 |
Sherrie Williams Md | CHAIR-ELECT | 1 | $0 |
Robert Chapman Md | DIRECTOR | 1 | $0 |
Sam Ross Md | CHAIR | 1 | $0 |
James Chip Falahee | SECRETARY | 1 | $0 |
Nicole Shoquist | DIRECTOR | 1 | $0 |
Patricia Vilt | TREASURER | 1 | $0 |
Mark Birdwhistell | IMMEDIATE PAST CHAIR | 1 | $0 |
Charles Hart Md | DIRECTOR | 1 | $0 |
Donald Davies | DIRECTOR | 1 | $0 |
Bruce Siegel Md | DIRECTOR | 1 | $0 |
Cynthia Martens | DIRECTOR | 1 | $0 |
Michael Bonck | PHARMACY/CLINICAL SEAT | 1 | $0 |
Tim Maurice | DIRECTOR | 1 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/201933179349305733_public.xml